CRL – charles river laboratories international, inc. (US:NASDAQ)
Stock Stats
News
12/3
05:06 pm
crl
Low
Charles River Laboratories (CRL) Shares Skyrocket, What You Need To Know [Yahoo! Finance]
12/1
09:02 pm
crl
Low
Charles River Laboratories International (NYSE:CRL) was given a new $185.00 price target on by analysts at Morgan Stanley.
12/1
03:42 pm
crl
Low
HALPER SADEH LLC ENCOURAGES CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
12/1
08:00 am
crl
Low
Charles River Laboratories to Present at Evercore Healthcare Conference
11/24
12:53 pm
crl
Low
Charles River Laboratories Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Charles River Laboratories International, Inc. - CRL
11/5/2025
07:00 am
CRL
-5.8%
BEAT
8/6/2025
07:00 am
CRL
-11.6%
BEAT
5/7/2025
07:01 am
CRL
13.2%
BEAT
2/19/2025
07:00 am
CRL
6.0%
BEAT
11/17
10:23 am
Upgrades
Hold
Buy
Argus
Medium
-3.1%
11/17
10:23 am
Upgrades
Hold
Buy
Argus
Medium
-3.1%
11/17
08:15 am
Upgrades
HOLD
BUY
ARGUS
Medium
-3.7%
11/17
08:15 am
Upgrades
HOLD
BUY
ARGUS
Medium
-3.7%
11/11
11:35 am
Maintains
Equal-Weight
Equal-Weight
Morgan Stanley
Low
1.6%
12/3
07:29 am
crl
Medium
Form 8-K CHARLES RIVER LABORATORI For: Dec 03
11/17
08:06 am
crl
Medium
Form 8-K CHARLES RIVER LABORATORI For: Nov 14
11/14
04:59 pm
crl
Medium
Form SCHEDULE 13G/A CHARLES RIVER LABORATORI Filed by: NOMURA HOLDINGS INC
11/12
09:35 am
crl
Low
Form SCHEDULE 13G/A CHARLES RIVER LABORATORI Filed by: WELLINGTON MANAGEMENT GROUP LLP
11/7
04:35 pm
crl
Low
Form 4 CHARLES RIVER LABORATORI For: Nov 06 Filed by: Knell Michael Gunnar
Show more
Top News Gainers
2/11 Charles River Laboratories Announces Fourth-Quarter and Full-Year 2019 Results and Provides 2020 Guidance 11.8%
4/3 Immunologist says he has a possible cure for the coronavirus [FOX News] 8.9%
3/2 Charles River Laboratories Intl. Inc (NYSE: CRL) is now covered by analysts at Deutsche Bank AG. They set a "buy" rating and a $190.00 price target on the stock. 4.3%
3/30 Charles River Laboratories Intl. Inc (NYSE: CRL) had its price target lowered by analysts at Wells Fargo & Co from $200.00 to $145.00. They now have an "overweight" rating on the stock. 4.2%
3/4 Charles River Laboratories Adds Nancy C. Andrews, M.D., Ph.D., to Board of Directors 4.0%
3/26 Charles River Laboratories Intl. Inc (NYSE: CRL) had its price target lowered by analysts at Barclays PLC from $170.00 to $154.00. They now have an "equal weight" rating on the stock. 3.9%
6/19 Laetose(TM), Healthier Sugar Naturally Modified From Table Sugar, Unveiled at Harvard Health Summit 3.5%
3/10 Charles River Laboratories To Participate In Barclays Global Healthcare Conference 3.2%
2/13 Charles River Laboratories Intl. Inc (NYSE: CRL) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 2.8%
11/8 Charles River Laboratories Intl. Inc (NYSE: CRL) had its price target lowered by analysts at UBS Group AG from $147.00 to $145.00. They now have a "neutral" rating on the stock. 2.5%
Top News Decliners
3/19 Doctor says he's 3-4 weeks from developing treatment to 'neutralize' coronavirus [FOX News] -18.6%
4/21 Charles River Laboratories Intl. Inc (NYSE: CRL) was downgraded by analysts at Jefferies Financial Group Inc from a "buy" rating to a "hold" rating. They now have a $139.00 price target on the stock. -6.4%
5/7 Q1/2019 3/30/2019 EPS 1.400 ZacksConsensus 1.380 ActVsEst 0.020 - Beat -5.7%
3/4 Form 3 CHARLES RIVER LABORATORI For: Mar 02 Filed by: Andrews Nancy C -4.9%
7/31 Q2/2019 6/29/2019 EPS 1.630 ZacksConsensus 1.550 ActVsEst 0.080 - Beat -4.5%
10/21 Charles River Laboratories Announces Offering of $500 Million of Senior Notes -4.4%
3/17 Charles River Laboratories Intl. Inc (NYSE: CRL) had its price target lowered by analysts at SunTrust Banks, Inc. from $188.00 to $124.00. They now have a "buy" rating on the stock. -4.0%
9/9 Charles River Laboratories Announces Updates to Microbial Solutions Product Portfolio -3.7%
10/1 Charles River Laboratories Adds Virginia M. Wilson to Board of Directors -3.2%
3/27 Charles River Laboratories Intl. Inc (NYSE: CRL) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $152.00 price target on the stock. -2.9%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3